TNF and rheumatoid arthritis: Moreover, differences in the clinical effectiveness of the therapy with anti- TNF-α has been found in RA patients, with particular regard to non-responder patients in which the circulating inflammatory profile and the oxidative stress biomarkers remained significantly elevated after 6 months of therapy (Luque-Tévar et al., 2021).